To investigate whether PRDX2 plays an oncogenic role in vivo, we performed a xenograft tumor growth experiment by subcutaneously injecting shPRDX2-HCT116 and NC-HCT116 cells into the dorsal flank. This evidence concerns the gene PRDX2 and neoplasm.